1832 Asset Management L.P. Biomarin Pharmaceutical Inc Transaction History

1832 Asset Management L.P.

$51.7 Billion
Q1 2024

A detailed history of 1832 Asset Management L.P. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, 1832 Asset Management L.P. holds 19,721 shares of BMRN stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,721

Previous 737,221 97.32%

Holding current value

$1.62 Million

Previous $71.1 Million 97.58%

% of portfolio

0.0%

Previous 0.14%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $60.1 Million - $71 Million	-717,500 Reduced 97.32%	19,721 $1.72 Million
Q4 2023 Feb 13, 2024	BUY	$76.22 - $98.51 $20.1 Million - $26 Million	263,781 Added 55.72%	737,221 $71.1 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $40.3 Million - $44.7 Million	473,440 New	473,440 $41.9 Million
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $19.9 Million - $23 Million	229,415 Added 151.62%	380,721 $33 Million
Q1 2023 May 12, 2023	SELL	$87.74 - $117.27 $85.5 Million - $114 Million	-974,500 Reduced 86.56%	151,306 $14.7 Million

Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $22.4 Million - $30 Million	-276,246 Reduced 19.7%	1,125,806 $117 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $16.4 Million - $19.4 Million	200,170 Added 16.65%	1,402,052 $119 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $50.1 Million - $60.9 Million	701,500 Added 140.19%	1,201,882 $99.6 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $8.21 Million - $10.2 Million	110,490 Added 28.34%	500,382 $38.1 Million
Q4 2021 Feb 15, 2022	BUY	$71.72 - $91.47 $4.36 Million - $5.57 Million	60,842 Added 18.49%	389,892 $34.7 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $16.3 Million - $18.6 Million	217,413 Added 194.75%	329,050 $25.4 Million
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $8.34 Million - $10.1 Million	111,637 New	111,637 $8.28 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $70.4 Million - $128 Million	-979,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $74.8 Million - $117 Million	940,078 Added 2396.81%	979,300 $119 Million
Q1 2020 May 26, 2020	BUY	$71.37 - $96.85 $2.8 Million - $3.8 Million	39,222 New	39,222 $3.22 Million

Others Institutions Holding BMRN

# of Institutions

623

Shares Held

181M

Call Options Held

1.73M

Put Options Held

1.73M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.

Account

1832 Asset Management L.P. Biomarin Pharmaceutical Inc Transaction History